 |
|
|
Finadyne Granules 10g (pack of 10) |
|
Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic activities. Finadyne Granules are indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders in the horse.
|
|
Presentation
White to cream coloured granules containing 250 mg flunixin, as flunixin meglumine BP (Vet) per 10 gram packet.
Uses
Flunixin meglumine is a potent, non-steroidal, non-narcotic analgesic with anti-inflammatory, anti-endotoxic and anti-pyretic activities. Finadyne Granules are indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders in the horse.
|
|
Dosage and administration
Finadyne Granules are for oral administration only.
The recommended dosage is the contents of one packet (10 g) Finadyne Granules per 227 kg (500 lb) bodyweight (equivalent to 1.1 mg flunixin per kg) once daily for up to five consecutive days according to clinical response.
Finadyne Granules are easily administered by sprinkling on a small amount of food.
|
|
Contra-indications, warnings, etc
Animals must not be slaughtered for human consumption during treatment.
Horses may be slaughtered for human consumption only after 7 days from the last treatment.
Do not exceed the stated dose or the duration of treatment.
Do not administer to pregnant mares. Studies to demonstrate safety in pregnant mares have not been conducted.
Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is hypersensitivity to the product.
Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
Do not administer other NSAIDs concurrently or within 24 hours of each other.
Concurrent administration of potentially nephrotoxic drugs should be avoided.
It is preferable that NSAID’s which inhibit prostaglandin synethesis are not administered to animals undergoing general anaesthesia until fully recovered.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
For animal treatment only.
Keep out of the reach of children.
Direct contact with the skin should be kept to a minimum.
Avoid contact with eyes. If contact occurs rinse immediately with clear running water.
Wash hands after use.
Pharmaceutical precautions
Do not store above 25°C. Discard any remaining feed.
Dispose of any unused product in accordance with guidance from your local waste regulation authority.
|
|
Legal category
POM-V (previously POM).
Packaging Quantities
Packets containing 10 g Finadyne Granules in boxes of 10 packets.
Further information
Flunixin meglumine is also presented as Finadyne Solution and Finadyne Paste which may be used as an alternative to Finadyne Granules. A suggested dosage regime is an initial injection of Finadyne Solution followed by Finadyne Granules or Finadyne Paste on subsequent days.
Studies in horses have shown onset of activity occurs two hours after oral administration. Peak response occurs between 12 and 16 hours and the duration of activity is 24 to 36 hours.
Veterinary Surgeons administering NSAIDs to racehorses should refer to Section 4.4 of the RCVS Guide to Professional Conduct. Section 4.4.7 states, ``If a veterinarian recommends the discontinuance of any substance . . . not less than eight days before racing (even though such a period may be longer than is necessary in many instances) he should be able to feel sure that he has catered for all but the most exceptional cases''.
Marketing authorisation number
Vm 0201/4008.
|
|
|
